ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Elevated serum folic acid concentrations were associated with higher mRNA expression of DHFR gene in patients with hereditary spherocytosis (2014)
Paniz, Clovis; Lucena, Maylla Rodrigues; Bertinato, Juliano Felix; Amorim, Patrícia Mendonça da Silva ; Gomes, Guilherme Wataru; Figueiredo, Maria Stella; Green, Ralph; Cançado, Rodolfo; Domingos, Claudia R Bonini; Bláia-D'Avila, Vera; Cliquet, Marcelo; Guerra-Shinohara, Elvira Maria
Source: Blood. Conference titles: Annual Meeting of the American Society Hematology (ASH). Unidade: FCF
Subjects: ÁCIDO FÓLICO, RNA MENSAGEIRO, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANIZ, Clovis et al. Elevated serum folic acid concentrations were associated with higher mRNA expression of DHFR gene in patients with hereditary spherocytosis. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2014
APA
Paniz, C., Lucena, M. R., Bertinato, J. F., Amorim, P. M. da S., Gomes, G. W., Figueiredo, M. S., et al. (2014). Elevated serum folic acid concentrations were associated with higher mRNA expression of DHFR gene in patients with hereditary spherocytosis. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Paniz C, Lucena MR, Bertinato JF, Amorim PM da S, Gomes GW, Figueiredo MS, Green R, Cançado R, Domingos CRB, Bláia-D'Avila V, Cliquet M, Guerra-Shinohara EM. Elevated serum folic acid concentrations were associated with higher mRNA expression of DHFR gene in patients with hereditary spherocytosis. Blood. 2014 ; 124( 21 p. 1-3):[citado 2024 nov. 18 ]
Vancouver
Paniz C, Lucena MR, Bertinato JF, Amorim PM da S, Gomes GW, Figueiredo MS, Green R, Cançado R, Domingos CRB, Bláia-D'Avila V, Cliquet M, Guerra-Shinohara EM. Elevated serum folic acid concentrations were associated with higher mRNA expression of DHFR gene in patients with hereditary spherocytosis. Blood. 2014 ; 124( 21 p. 1-3):[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia (2011)
Vivona, Douglas; Lima, Luciene Terezina; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Source: Blood. Conference titles: Annual Meeting and Exposition of the American Society of Hematology (ASH). Unidade: FCF
Subjects: LEUCEMIA MIELOIDE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2011
APA
Vivona, D., Lima, L. T., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2011). ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Vivona D, Lima LT, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli M, Chiattone CS, Guerra-Shinohara EM. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. 2011 ; 118( 21): 618 res. 604.[citado 2024 nov. 18 ]
Vancouver
Vivona D, Lima LT, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli M, Chiattone CS, Guerra-Shinohara EM. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. 2011 ; 118( 21): 618 res. 604.[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia (2011)
Lima, L. T; Vivona, Douglas; Bueno, C. T; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Source: Revista Brasileira de Hematologia e Hemoterapia. Conference titles: Congresso Brasileiro de Hematologia e Hemoterapia. Unidade: FCF
Subjects: LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, L. T et al. Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2011
APA
Lima, L. T., Vivona, D., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2011). Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Lima LT, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. 2011 ; 33 144-145 res. 0340.[citado 2024 nov. 18 ]
Vancouver
Lima LT, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. 2011 ; 33 144-145 res. 0340.[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate (2011)
Lima, Luciene Terezinha de; Vivona, Douglas; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Chiattone, Carlos Sérgio; Zanichelli, Maria Aparecida; Guerra-Shinohara, Elvira Maria
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidade: FCF
Subjects: LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Luciene Terezinha de et al. ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2011
APA
Lima, L. T. de, Vivona, D., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Chiattone, C. S., et al. (2011). ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Chiattone CS, Zanichelli MA, Guerra-Shinohara EM. ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 66 res. FCF128.[citado 2024 nov. 18 ]
Vancouver
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Chiattone CS, Zanichelli MA, Guerra-Shinohara EM. ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 66 res. FCF128.[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia (2011)
Vivona, Douglas; Lima, Luciene Terezina; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Source: Blood. Conference titles: American Society of Hematology (ASH). Unidade: FCF
Subjects: LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2011
APA
Vivona, D., Lima, L. T., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2011). ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Vivona D, Lima LT, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli M, Chiattone CS, Guerra-Shinohara EM. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. 2011 ; 118( 21):[citado 2024 nov. 18 ]
Vancouver
Vivona D, Lima LT, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli M, Chiattone CS, Guerra-Shinohara EM. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. 2011 ; 118( 21):[citado 2024 nov. 18 ]

USP Schools

ReP

Filtros

Authors